Skip to content
Search
Elizabeth Glaser Pediatric AIDS Foundation logo
    • Elizabeth’s Story
    • Our Mission
    • Our Leadership
    • Our Partners
    • Our Ambassadors
    • View All

  • Where We Work

    We are working toward an AIDS-free generation in over 20 countries.

    Featured Countries

    • Tanzania
    • Lesotho
    • Kenya
      • Where We Work

    Our Work

    We apply our expertise across the full spectrum of children’s health.

    Featured Work

    • Prevention of Mother-to-Child HIV Transmission
    • Pediatric HIV
    • Pediatric Tuberculosis (TB)
    • Adolescents, Youth, and HIV
    • Maternal, Newborn, and Child Health
    • Advanced HIV Disease
    • Digital Health
    • Public Policy and Advocacy
      • View All
  • Ideas & Impact
    • Ways to Give
    • Become a Partner
    • Join Team EGPAF
    • View All
Donate
Elizabeth Glaser Pediatric AIDS Foundation logo
    • Elizabeth’s Story
    • Our Mission
    • Our Leadership
    • Our Partners
    • Our Ambassadors
    • View All

  • Where We Work

    We are working toward an AIDS-free generation in over 20 countries.

    Featured Countries

    • Tanzania
    • Lesotho
    • Kenya
      • Where We Work

    Our Work

    We apply our expertise across the full spectrum of children’s health.

    Featured Work

    • Prevention of Mother-to-Child HIV Transmission
    • Pediatric HIV
    • Pediatric Tuberculosis (TB)
    • Adolescents, Youth, and HIV
    • Maternal, Newborn, and Child Health
    • Advanced HIV Disease
    • Digital Health
    • Public Policy and Advocacy
      • View All
  • Ideas & Impact
    • Ways to Give
    • Become a Partner
    • Join Team EGPAF
    • View All
Donate
Search

Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy

Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy › Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy

Journal Article

Join Our Fight

With your help, we can and WILL achieve an AIDS-free generation. Stay up-to-date on the progress we’re making toward ending HIV/AIDS in children.
Opt-In
Elizabeth Glaser Pediatric AIDS Foundation
  • About
    • Elizabeth’s Story
    • Our Mission
    • Our Leadership
    • Our Partners
    • Our Ambassadors
  • Where We Work
  • What We Do
    • Prevention of Mother-to-Child Transmission
    • Pediatric HIV
    • Pediatric Tuberculosis (TB)
    • Adolescents, Youth, and HIV
    • Maternal, Newborn, and Child Health
    • Advanced HIV Disease
    • Digital Health
    • Public Policy and Advocacy
  • Ideas & Impact
  • Join Us
    • Give
    • Partner
    • Careers

For more than 35 years, EGPAF has carried forward Elizabeth Glaser’s fight. She taught us that specialized focus leads to breakthroughs. Her legacy is not just in the lives already saved, but in the vision of a world where no child is born with HIV.

Donate
  • Contracting Opportunities
  • Contact Us
  • Financial Information and Annual Reports
  • Ethics and Accountability
  • Privacy Policy

While the Elizabeth Glaser Pediatric AIDS Foundation makes effort to use photos which accurately depict the actions, topics, or populations referenced, unless specifically indicated, the photographs in this website do not imply program participation, health status, attitude, behavior, or action on the part of persons who appear therein.

1350 Eye St NW, Suite 400, Washington DC 20005 | 202.296.9165 | Tax ID: #95-4191698

© 2025 Elizabeth Glaser Pediatric AIDS Foundation. All Rights Reserved.

  • Better Business Buerua Accredited Charity badge
  • Charity Navigator badge
  • Charity Watch A-Rated badge